E-selectin as a prognostic factor of patients who hospitalized for respiratory inflammation diseases; a single institutional study

Masamichi Sato (Yamagata, Japan), Masamichi Sato, Yoko Shibata, Sumito Inoue, Akira Igarashi, Yoshikane Tokairin, Tomomi Kimura, Keiko Yamauchi, Takako Nemoto, Kento Sato, Hiroshi Nakano, Takahito Yagihashi, Isao Kubota

Source: International Congress 2016 – Clinical characteristics of asthma
Session: Clinical characteristics of asthma
Session type: Thematic Poster
Number: 628

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Masamichi Sato (Yamagata, Japan), Masamichi Sato, Yoko Shibata, Sumito Inoue, Akira Igarashi, Yoshikane Tokairin, Tomomi Kimura, Keiko Yamauchi, Takako Nemoto, Kento Sato, Hiroshi Nakano, Takahito Yagihashi, Isao Kubota. E-selectin as a prognostic factor of patients who hospitalized for respiratory inflammation diseases; a single institutional study. Eur Respir J 2016; 48: Suppl. 60, 628

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014

Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

The analysis of prognostic factors in patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015


Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
Source: Eur Respir J 2010; 35: 540-548
Year: 2010



Interstitial lung diseases in infants and children
Source: Eur Respir J 2008; 31: 658-666
Year: 2008



The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Risk factors for postoperative acute exacerbation of interstitial lung diseases: a matched case-control study
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019



Clinical study of pediatric interstitial lung diseases in China
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014

Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Metabolic syndrome in patients with COPD and their association with systemic inflammation
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia
Source: International Congress 2014 – ILDs 3
Year: 2014

Mortality and survival predictor in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Markers of injury and fibrosis in occupational interstitial lung diseases (OILD)
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016